Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Albemarle Selling Ibuprofen Unit

by Rick Mullin
April 21, 2014 | A version of this story appeared in Volume 92, Issue 16

SI Group has agreed to acquire Albemarle’s ibuprofen, antioxidants, and propofol businesses for an undisclosed sum. Albemarle, a leading supplier of ibuprofen, characterizes the deal as a step in its plan to focus on core businesses such as catalysts, bromine, custom fine chemicals, and performance chemicals. SI Group, a manufacturer of chemical intermediates, resins, and other nonpharmaceutical chemicals, says the acquisition will advance an effort to develop a pharmaceutical chemical business. Frank A. Bozich, CEO of the Schenectady, N.Y.-based company, says the deal is the largest in SI Group’s history.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.